Hypoglycaemia frequency and physiological response to double or triple doses of once weekly insulin icodec vs. once-daily insulin glargine U100 in type 2 diabetes

被引：0

作者：

Svehlikova, Eva ^{[1
]}

Arfelt, Kristine Niss ^{[2
]}

Cailleteau, Roma ^{[2
]}

Deller, Sigrid ^{[1
]}

Thomsen, Karen Margret Due ^{[3
]}

Hart, Marlies ^{[1
]}

Mursic, Ines ^{[1
]}

Pieber, Thomas ^{[1
]}

Haahr, Hanne ^{[2
]}

机构：

[1] Med Univ Graz, Graz, Austria

[2] Novo Nordisk, Soborg, Denmark

[3] Novo Nordisk, Aalborg, Denmark

来源：

WIENER KLINISCHE WOCHENSCHRIFT | 2022年 / 134卷 / SUPPL 4期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：262 / 263

页数：2

共 50 条

[1] Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial
Thomas R. Pieber
Kristine N. Arfelt
Roman Cailleteau
Marlies Hart
Soumitra Kar
Ines Mursic
Eva Svehlikova
Martina Urschitz
Hanne Haahr
[J]. Diabetologia, 2023, 66 : 1413 - 1430
[2] Hypoglycaemia frequency and physiological response after double or triple doses of once-weekly insulin icodec vs once-daily insulin glargine U100 in type 2 diabetes: a randomised crossover trial
Pieber, Thomas R.
Arfelt, Kristine N.
Cailleteau, Roman
Hart, Marlies
Kar, Soumitra
Mursic, Ines
Svehlikova, Eva
Urschitz, Martina
Haahr, Hanne
[J]. DIABETOLOGIA, 2023, 66 (08) : 1413 - 1430
[3] Hypoglycaemia frequency and physiological response to double or triple doses of once-weekly insulin icodec versus once-daily insulin glargine in type 2 diabetes
Pieber, T. R.
Arfelt, K. N.
Cailleteau, R.
Thomsen, K. M. Due
Hart, M.
Mursic, I.
Svehlikova, E.
Urschitz, M.
Haahr, H.
[J]. DIABETOLOGIA, 2022, 65 (SUPPL 1) : S333 - S333
[4] Hypoglycemia Frequency and Physiological Response to Double or Triple Doses of Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine in T2D
Svehlikova, Eva
Arfelt, Kristine Niss
Cailleteau, Roman
Deller, Sigrid
Thomsen, Karen Margrete
Hart, Marlies
Mursic, Ines
Pieber, Thomas
Haahr, Hanne
[J]. DIABETES, 2022, 71
[5] CGM-based parameters for once-weekly insulin icodec vs once-daily insulin glargine U100 in insulin-naive patients with type 2 diabetes
Lingvay, I.
Bang, R. Beck
Liu, L.
Mader, J.
Pettus, J.
Wagner, L.
Mathieu, C.
[J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 265 - 266
[6] Similar hypoglycaemia duration with once-weekly insulin icodec vs insulin glargine U100 in insulin naive or experienced patients with type 2 diabetes
Silver, R.
Asong, M.
Begtrup, K.
Heller, S. R.
Liu, L.
Rosenstock, J.
[J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 73 - 73
[7] Once-Weekly Insulin Icodec vs. Once-Daily Insulin Glargine U100 for type 2 diabetes: a systematic review and meta-analysis of phase 2 randomized controlled trials
Ribeiro e Silva, Rodrigo
Gauza, Mateus de Miranda
Schramm Guisso, Maria Eduarda
Nunes da Silva, Julia Opolski
Kohara, Suely Keiko
[J]. ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2023, 67 (05):
[8] CGM outcomes and hypoglycaemia duration with once-weekly insulin icodec versus once-daily insulin glargine u100 in insulin-naive type 2 diabetes: ONWARDS 1 exploratory analysis
Bergenstal, R.
Watt, S. Kehlet
Matos, A. S. A.
Lingvay, I.
Mader, J. K.
Nishida, T.
Rosenstock, J.
[J]. DIABETOLOGIA, 2023, 66 (SUPPL 1) : S397 - S397
[9] CGM-based measurements for once-weekly insulin icodec vs once-daily insulin glargine U100 in insulin-treated patients with type 2 diabetes: a post hoc analysis
Bajaj, H. S.
Bang, R. Beck
Gowda, A.
Liu, L.
Senior, P.
Bergenstal, R.
[J]. DIABETOLOGIA, 2021, 64 (SUPPL 1) : 266 - 266
[10] Once-weekly basal insulin icodec offers comparable efficacy and safety vs once-daily insulin glargine U100 in insulin naive patients with type 2 diabetes inadequately controlled on OADs
Rosenstock, J.
Kjaersgaard, M.
Moller, D.
Hansen, M.
Goldenberg, R.
[J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S28 - S29

← 1 2 3 4 5 →